上海股票开户 is a privately-owned high-tech company founded in 2000. It is located in a coastal scenic and convenient transportation along the coast of southeast China port city ---- Taizhou, Zhejiang province.
The company’s main business is the production and marketing of APIs and key intermediates. Main API products include Gemfibrozil, Meloxicam, Fenofibrate, Amiodarone HCl and Gabapentin. All of the company’s products meet USP, BP, EP and JP requirements. Intermediates are mainly sophisticated chemicals contract-manufactured for customers. 90% of the company’s products are exported. Excel has developed a product line aimed for the higher-end markets such as the USA, EU and with sales also to the South American and South-east Asian markets.
The company has continuously improved its cGMP quality management systems and maintains multiple GMP compliant plants. Since set up, the company actively promotes the construction of quality management system. In 2005, the company approved by CFDA and obtains the GMP certificate which is issued by CFDA; passed the FDA establishment inspection in 2009, 2013 and 2016 with no 483; received EU COS certificate in 2011 and 2016; and received ISO9001 in 2016. The company also maintains a multi-purpose pilot production plant with a clean area and a R&D center thus can provide solid regulatory support for customers.
Excel Pharma’s mission is to provide high quality products to customers and achieve sustainable growth by continuously improving its management systems. We committed to learn from advanced management experience in pharmaceutical production, continue to promote and enhance the management level, to promote cooperation.
We warmly welcome cooperation from all over the world.